Product References — Pooled Human AB Serum Off The Clot Heat Inactivated

Expression of Placenta-Specific 1 and its Potential for Eliciting Anti-Tumor Helper T-cell Responses in Head and Neck Squamous Cell Carcinoma

Posted by Adam Awdish on

Expression of Placenta-Specific 1 and its Potential for Eliciting Anti-Tumor Helper T-cell Responses in Head and Neck Squamous Cell Carcinoma

Pooled Human AB Serum Off The Clot from Innovative Research was used in the following study:   Expression of Placenta-Specific 1 and its Potential for Eliciting Anti-Tumor Helper T-cell Responses in Head and Neck Squamous Cell Carcinoma Ryusuke Hayashi, Toshihiro Nagato, Takumi Kumai, Kenzo Ohara, Mizuho Ohara, Takayuki Ohkuri, Yui Hirata-Nozaki, Shohei Harabuchi, Akemi Kosaka, Marino Nagata, Yuki Yajima, Syunsuke Yasuda, Kensuke Oikawa, Michihisa Kono, Kan Kishibe, Miki Takahara, Akihiro Katada, Tatsuya Hayashi, Esteban Celis, Yasuaki Harabuchi, and Hiroya Kobayashi OncoImmunology December 29, 2020 Various cancers of the head and neck are frequent around the globe, with the most common...

Read more →

Enhanced Influenza A H1N1 T-Cell Epitope Recognition and Cross-Reactivity to Protein-O-Mannosyltransferase 1 in Pandemrix-Associated Narcolepsy Type 1

Posted by Adam Awdish on

Enhanced Influenza A H1N1 T-Cell Epitope Recognition and Cross-Reactivity to Protein-O-Mannosyltransferase 1 in Pandemrix-Associated Narcolepsy Type 1

Pooled Human Serum, Heat Inactivated from Innovative Research was used in the following study:   Enhanced Influenza A H1N1 T-Cell Epitope Recognition and Cross-Reactivity to Protein-O-Mannosyltransferase 1 in Pandemrix-Associated Narcolepsy Type 1 A. Vuorela, T. L. Freitag, K. Leskinen, H. Pessa, T. Härkönen, I. Stracenski, T. Kirjavainen, P. Olsen, O. Saarenpää-Heikkilä, J. Ilonen, M. Knip, A. Vaheri, M. Partinen, P. Saavalainen, S. Meri & O. Vaarala Nature Communications April 16, 2021 Narcolepsy type 1 (NT1) is a chronic condition of the brain that causes patients to exhibit excessive daytime drowsiness, cataplexy, and disruption of nocturnal sleep patterns. NT1 is strongly...

Read more →

No Evidence of Autoimmunity to Human OX1 or OX2 Orexin Receptors in Pandemrix-Vaccinated Narcoleptic Children

Posted by Adam Awdish on

No Evidence of Autoimmunity to Human OX1 or OX2 Orexin Receptors in Pandemrix-Vaccinated Narcoleptic Children

Pooled Human AB Serum Off The Clot Heat Inactivated from Innovative Research was used in the following study:   No Evidence of Autoimmunity to Human OX1 or OX2 Orexin Receptors in Pandemrix-Vaccinated Narcoleptic Children Krister Melen, Pinja Jalkanen, Jyrki P. Kukkonen, Markku Partinen, Hanna Nohynek, Arja Vuorela, Outi Vaarala, Tobias L. Freitag, Seppo Meri, Ilkka Julkunen Journal of Translational Autoimmunity May 1, 2020 Narcolepsy is a chronic neurological disorder where diagnoses are divided into two groups; Narcolepsy Type 1 (NT1) is characterized by excessive daytime sleepiness, disturbed sleep at night, and cataplexy. People suffering from NT1 may also experience symptoms...

Read more →

The Safety and Efficacy of Live Viral Vaccines in Patients With Cartilage-Hair Hypoplasia

Posted by Adam Awdish on

The Safety and Efficacy of Live Viral Vaccines in Patients With Cartilage-Hair Hypoplasia

Pooled Human AB Serum Off The Clot Heat Inactivated from Innovative Research was used in the following study:   The Safety and Efficacy of Live Viral Vaccines in Patients With Cartilage-Hair Hypoplasia Svetlana Vakkilainen, Iivari Kleino, Jarno Honkanen, Harri Salo, Leena Kainulainen, Michaela Gräsbeck, Eliisa Kekäläinen, Outi Mäkitie, and Paula Klemetti Frontiers in Immunology August 11, 2020 Cartilage-hair hypoplasia (CHH) is a rare skeletal dysplasia with combined immunodeficiency that is caused by genetic mutations. The degree of immunodeficiency experienced by patients with CHH can vary greatly, ranging from asymptomatic lymphopenia to severe deficiencies requiring stem cell transplants. Because of this,...

Read more →

CMV and EBV targets recognized by tumor-infiltrating B lymphocytes in pancreatic cancer and brain tumors

Posted by Leanne Kodsmann on

CMV and EBV targets recognized by tumor-infiltrating B lymphocytes in pancreatic cancer and brain tumors

Pooled Human AB Serum from Innovative Research was used in the following study:   CMV and EBV targets recognized by tumor-infiltrating B lymphocytes in pancreatic cancer and brain tumors Qingda Meng, Davide Valentini, Martin Rao, Ernest Dodoo & Markus Maeurer Scientific Reports November 2018. Scientific Reportsvolume 8, Article number: 17079 (2018) "... TILs from patients with pancreatic cancer or brain tumor were isolated and expanded in vitro with the addition of IL-2, IL-15 and IL-21 as previously described. Briefly, fresh tumor tissue was cut into 1-2 mm pieces using a sterile scalple, washed twice with cold PBS and cultured in...

Read more →

×